Review

A new target of antiplatelet therapy: glycoprotein Ⅵ

  • CHEN Yi-zhu ,
  • ZHANG Jun-feng
Expand
  • Department of Cardiology, Shanghai Third People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China

Online published: 2015-08-27

Supported by

Shanghai Shen-Kang Technique Expansion Project, SHDC12012210; Baoshan District Science and Technology Commission Project, 12-E-63

Abstract

Antiplatelet therapy plays a significant role in the treatment of cardiovascular disease. Now there are many drugs available for clinical application, but the curative effect is unsatisfactory. Complications such as bleeding are major problems. So it is urgent to find efficient and safe new drugs. Glycoprotein Ⅵ (GP Ⅵ) is one of the many receptors on platelet membrane and is also a new direction for developing antithrombotic drugs. This paper reviews studies relevant to GP Ⅵ.

Cite this article

CHEN Yi-zhu , ZHANG Jun-feng . A new target of antiplatelet therapy: glycoprotein Ⅵ[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2015 , 35(7) : 1078 . DOI: 11.3969/j.issn.1674-8115.2015.07.027

Outlines

/